Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].
Saved in:
| Title: | Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745]. |
|---|---|
| Authors: | Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea; Department of Medical Device Engineering and Management, College of Medicine, Yonsei University, Seoul 06229, the Republic of Korea., Lee S; Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim CG; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Son W; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Park JW; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Yoon SO; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Shin SJ; Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Hong HJ; Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Koh YW; Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Lim JY; Department of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Park YM; Department of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Wee CW; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim KH; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Lee CG; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim JW; Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim J; Department of Radiology & Research Institute of Radiological Science & Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, the Republic of Korea., Suh PS; Department of Radiology & Research Institute of Radiological Science & Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kuh SU; Department of Medical Device Engineering and Management, College of Medicine, Yonsei University, Seoul 06229, the Republic of Korea; Department of Neurosurgery, Spine and Spinal Cord Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim DH; Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Sim NS; Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea. |
| Source: | Oral oncology [Oral Oncol] 2026 Jun 20, pp. 108052. Date of Electronic Publication: 2026 Jun 20. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
